The success ofthe UCLA-CMCR in the last funding period is a reflection ofthe fact that Core A achieved its goal of maximizing the benefit UCLA can give to the CMCR through the efforts of an integrated executive committee made up of senior investigators, working together with experienced administrators. Core A has established three major levels of organization to ensure effective planning, scientific exchange, oversight, and educational success. These are the Executive Committee, and the outstanding scientists on the Internal and the External Scientific Review Groups (ISAG/ESAG). The Executive Committee ofthe CMCR is composed of Drs. McBride, SchiestI and Cheng who are all deeply immersed in the scientific fabric of UCLA and play numerous leadership roles locally, nationally and internationally. The UCLA-CMCR is built around extremely strong multidisciplinary Projects and Cores that have grown in size as they incorporated personnel and ideas from Pilot Research Projects the best of what UCLA can offer in science. Dr. Gatti, past member of the Executive Committee, will chair the ISAG and continues to lead Pilot Project Program Core B. This ensures that the ISAG will continue to play a major role in identifying quality personnel and research projects for the future and that ISAG recommendations are fully incorporated into the UCLA-CMCR. The ESAG, which will continue to be Chaired by Dr. Morgan, will continue to guide the Executive Committee by performing quality assurance for all aspects of the Program and making recommendations as to directions in which to proceed. The Core will continue to promote interactions between investigators in full and pilot projects and Cores, in the CMCR network, with CMCR Program leaders, and with industry. This has been very successful in the last period as is seen by the large increase in the number of investigators participafing in the UCLA-CMCR regular meetings and symposia organized by this Core, and in participation in CMCR meetings. The Core will ensure Biostatistical support for all invesfigators. This will be provided by Dr. Sayre, who will be integrated into the Center's acfivities. Finally, the Core will be responsible for administrative, fiscal, and executive decisions, as well as scientific productivity and contributions to the CMCR Program as a whole.

Public Health Relevance

The UCLA-CMCR Program has, through the efforts of this Core, brought outstanding scientists to address the important issue of how best to mitigate radiafion damage occurring to people as a result of a nuclear accident or terrorist action. The Core also ensures that the Program is fiscally responsible and that the highest ethical and moral standards are maintained.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI067769-08
Application #
8380841
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
8
Fiscal Year
2012
Total Cost
$437,954
Indirect Cost
$197,437
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Micewicz, Ewa D; Sharma, Shantanu; Waring, Alan J et al. (2016) Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation. Int J Pept Res Ther 22:67-81
Wang, Wenyuan; Org, Tonis; Montel-Hagen, Amélie et al. (2016) MEF2C protects bone marrow B-lymphoid progenitors during stress haematopoiesis. Nat Commun 7:12376
Ratikan, Josephine A; Micewicz, Ewa D; Xie, Michael W et al. (2015) Radiation takes its Toll. Cancer Lett 368:238-45
Micewicz, Ewa D; Ratikan, Josephine A; Waring, Alan J et al. (2015) Lipid-conjugated Smac analogues. Bioorg Med Chem Lett 25:4419-27
Micewicz, Ewa D; Bahattab, Omar S O; Willars, Gary B et al. (2015) Small lipidated anti-obesity compounds derived from neuromedin U. Eur J Med Chem 101:616-26
Pai, Melody Y; Lomenick, Brett; Hwang, Heejun et al. (2015) Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol 1263:287-98
Schaue, Dörthe; Micewicz, Ewa D; Ratikan, Josephine A et al. (2015) Radiation and inflammation. Semin Radiat Oncol 25:4-10
Schaue, Dörthe; McBride, William H (2015) Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol 12:527-40
Damoiseaux, Robert (2014) UCLA's Molecular Screening Shared Resource: enhancing small molecule discovery with functional genomics and new technology. Comb Chem High Throughput Screen 17:356-68
Erde, Jonathan; Loo, Rachel R Ogorzalek; Loo, Joseph A (2014) Enhanced FASP (eFASP) to increase proteome coverage and sample recovery for quantitative proteomic experiments. J Proteome Res 13:1885-95

Showing the most recent 10 out of 78 publications